Publisher
Springer International Publishing
Reference27 articles.
1. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69–73. https://doi.org/10.1007/s10147-004-0392-6.
2. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398–404, 1404.e1. https://doi.org/10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.
3. Rojanaporn D, Chanthanaphak E, Boonyaopas R, Sujirakul T, Hongeng S, Ayudhaya SSN. Intra-arterial chemotherapy for retinoblastoma: 8-year experience from a Tertiary Referral Institute in Thailand. Asia Pac J Ophthalmol (Phila). 2019;8(3):211–7. https://doi.org/10.22608/APO.2018294. Epub 2019 Feb 4.
4. Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, Sripaiboonkij N. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12(9):2215–20.
5. Wongmas P, Jetsrisuparb A, Komvilaisak P, Suwanrungruang K, Choeyprasert W, Sriplung H, Wiangnon S. Incidences, trends and long term outcomes of retinoblastoma in three cancer registries, Thailand. Asian Pac J Cancer Prev. 2015;16(16):6899–902. https://doi.org/10.7314/apjcp.2015.16.16.6899.